The patents at issue were five patents Teva had listed in the Orange Book for its ProAir® HFA (albuterol sulfate) Inhalation Aerosol. The patents are described in the Federal Circuit opinion as ...

Earlier this year, two new laws were enacted that impact patent listings in the Orange Book (drugs) and Purple Book (biologics). The Orange Book Transparency Act primarily codifies current FDA ...

Google is cagey about exactly how it scans books for its digital library effort, but a patent reveals details--and the hurdles competitors face. Sometimes overlooked in the Sturm und Drang about ...

“Institution rates for Orange Book patents and biologic patents are slightly lower than overall institution rates, with biologic patents faring better than Orange Book patents at institution.” The U.S ...

“For many, there’s been a frustration about how to answer the form’s questions, which may have been written by an FDA expert and not a patent attorney. I think it helps everyone to modernize the ...